2-(methylazaniumyl)-3-[(2-methylpropan-2-yl)oxy]propanoate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(methylazaniumyl)-3-[(2-methylpropan-2-yl)oxy]propanoate
• 化学式: C8H17NO3
• 分子量: 175.23
• InChiKey: DLTSMSCPUUWYDX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• SUBSTITUTED URACILS AS CHYMASE INHIBITORS
  申请人：Bayer Pharma Aktiengesellschaft

  公开号：US20160244415A1

  公开（公告）日：2016-08-25

  Substituted uracil derivatives of formula (I), processes for their preparation, their use alone or in combinations for the treatment and/or prophylaxis of diseases, and their use for preparing medicaments for the treatment and/or prophylaxis of diseases.

  公式（I）中的尿嘧啶衍生物，它们的制备方法，它们单独或组合用于治疗和/或预防疾病，以及它们用于制备治疗和/或预防疾病的药物。
• PTERIDINONE COMPOUNDS AND USES THEREOF
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20190322673A1

  公开（公告）日：2019-10-24

  The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

  本发明提供了式I的化合物或其药学上可接受的盐，以及用于治疗细胞增殖性疾病（例如癌症）的药物组合物和使用方法。
• Kit for Highly Sensitive Detection Assays
  申请人：Bade Steffen

  公开号：US20090104633A1

  公开（公告）日：2009-04-23

  The present invention relates to kits comprising 2,4-dichlorophenoxyacetate derivatives as well as antibodies that bind to these derivatives. Inter alia, the kits can be used to label biomolecules for analytical and diagnostic applications. Some of the compounds described here can be used to label biomolecules under physiological conditions and without having to apply in situ activation. Furthermore, the presence of spacers within the 2,4-dichlorophenoxyacetate derivatives improves their binding to antibodies.

  本发明涉及包含2,4-二氯苯氧乙酸衍生物及与其结合的抗体的试剂盒。其中，这些试剂盒可用于标记生物分子以进行分析和诊断应用。这里描述的一些化合物可在生理条件下用于标记生物分子，而无需进行原位激活。此外，2,4-二氯苯氧乙酸衍生物中存在的空间支链改善了它们与抗体的结合。
• PEPTIDE-COMPOUND CYCLIZATION METHOD
  申请人：Chugai Seiyaku Kabushiki Kaisha

  公开号：EP2813512A1

  公开（公告）日：2014-12-17

  An object of the present invention is to provide methods of discovering drugs effective for tough targets, which have conventionally been discovered only with difficulty. The present invention relates to novel methods for cyclizing peptide compounds, and novel peptide compounds and libraries comprising the same, to achieve the above object.

  本发明的目的是提供发现对韧性靶标有效的药物的方法，这些靶标在传统上很难被发现。本发明涉及环化多肽化合物的新方法，以及实现上述目的的新的多肽化合物和由其组成的化合物库。
• Compounds for use in synthesis of peptidomimetics
  申请人：THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH

  公开号：US10919882B2

  公开（公告）日：2021-02-16

  Synthesis of O-benzotriazole and O-imidazole synthons are described. Uses of synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the synthons and uses of azapeptides and other peptidomimetics are also described.

  描述了 O-苯并三唑和 O-咪唑合成物的合成。还介绍了合成子在合成偶氮肽和其他拟肽物中的用途、由合成子合成的偶氮肽和其他拟肽物以及偶氮肽和其他拟肽物的用途。